QPS Neuro

QPS Neuro, the neuropharmacology division of QPS Austria GmbH, is a leading contract research organization (CRO) in drug discovery with extensive experience and expertise in preclinical central nervous system (CNS) services. Since 1999, QPS Neuro has grown into a prestigious high-quality CRO and an industry leader in the fields of neurodegenerative and rare diseases, covering research areas such as Alzheimer's disease, Parkinson's disease, ALS, dementia, Niemann-Pick disease, Gaucher's disease, autism, schizophrenia, and frontotemporal lobar degeneration. The company is not only highly reputable in the CNS field but also excels in preclinical efficacy studies, including in vitro molecular and cellular assays, proprietary in vivo transgenic mouse and rat models, and related analyses, offering comprehensive services to its broad client base.